BUTTERFLY NETWORK INC

Butterfly Network insider sale: 1.4M shares sold at $7.72, showing no major impact on stock. Learn how this move affects investors, revenue growth, and AI‑driven ultrasound tech.

Butterfly Network’s soaring valuation, insider RSU purchases, AI‑powered handheld ultrasounds, and FDA approvals highlight a bullish outlook for investors.

Insider RSU grant at Butterfly Network signals board confidence and a potential upside, yet high volatility and a negative P/E warn investors to tread carefully.

Explore Butterfly Network’s insider sales, AI‑driven ultrasound tech, reimbursement strategy and future growth—insights that could shape investor decisions.

Caezza Nicholas’s $4.52 sell‑to‑cover of 1,733 Butterfly Network shares sparks 485% online buzz but only a 0.18% price dip—insider routine, not a signal of trouble.

Butterfly Network’s recent insider sale of 147,518 shares by chief business officer Steve Cashman reflects routine tax‑cover activity, not a warning; the company’s strong Q1 earnings, AI‑driven portable imaging, and expanding reimbursement strategy …

Steve Cashman’s April 16 insider sale shows liquidity, not loss of confidence—insider moves, market impact, and what it means for investors.

CEO sell‑to‑cover on Butterfly Network shares: routine tax move, minimal impact on stock, but highlights insider confidence and ongoing earnings challenges.

Butterfly Network’s insider buying surge, led by CFO John Doherty’s RSU purchase, signals confidence amid AI‑driven iQ device growth and potential upside for investors and clinicians alike.

Butterfly Network insider selling: Steve Cashman’s 250K‑share sale shows liquidity‑driven moves amid a recent downgrade, yet the company’s AI‑powered ultrasound tech still promises upside if product milestones hit.